Fewer parts.No metal springs.Lower assembly complexity.One-piece polymer lancet.
FLX Medtech has developed a one-piece polymer lancet that integrates core device functions into a compact monolithic design. The result is a simplified alternative to conventional spring-based lancets, designed to reduce manufacturing complexity, material use and carbon footprint.
ONE-PIECE POLYMER LANCET
The problem with conventional lancets
Conventional disposable lancets rely on small multipart assemblies, separate springs, mixed materials and assembly steps that increase complexity across manufacturing, supply and end-of-life handling.
Multipart construction
Conventional lancets rely on several small components, including housing parts, trigger elements, needle carrier, spring and protective features.
Separate metal springs
A dedicated spring adds another material, assembly step, supplier dependency and disposal complication.
Mixed-material disposal
Plastic, steel and small locked assemblies are difficult to separate after use, limiting practical recovery.
High-volume single-use waste
Small disposable devices become large cumulative material flows across diabetes care, diagnostics and healthcare systems.
The FLX approach
FLX Lancet is designed as a one-piece polymer lancet that integrates core functions into the device geometry, reducing part count, removing the need for separate metal springs, and supporting lower material use, lower manufacturing complexity, and reduced carbon footprint.
One-piece lancet design
No separate metal springs
Integrated functional geometry
Built-in shielding and needle lockout
Designed for scalable manufacturing
Reduced material use and carbon footprint
Why this matters
FLX Lancet addresses more than device mechanics. It targets cost, material complexity, waste handling and scalability in a high-volume single-use medical device category.
High-volume disposable category
Lancets are small devices, but they are used repeatedly across diabetes care, diagnostics and capillary blood sampling.
Waste handling challenge
Used lancets become sharps-related healthcare waste and require safe handling, separation and disposal.
Simpler material flow
A one-piece polymer lancet reduces mixed-material complexity and improves the conditions for cleaner end-of-life handling.
Cost and sustainability impact
Lower part count and reduced material complexity support lower manufacturing cost, simpler assembly and reduced material-related footprint.
Activation and needle lockout
Pre-activation state and post-activation needle-lockout state
Functional proof of concept
Physical FLX Lancet prototypes have demonstrated actuation, skin penetration and blood drop formation in internal testing.
Development roadmap
Commercial pathway
FLX Medtech is exploring strategic routes including OEM partnership, licensing, manufacturing partnership, strategic investment and future supply discussions.
Seeking strategic funding and medtech partnerships
FLX Medtech is preparing the FLX Lancet for the next stage of regulatory pathway execution, manufacturability and commercialization planning. The company is seeking strategic funding, medical-device partners, manufacturing partners, regulatory support and market-entry collaboration.
Founder-led development
FLX Medtech is led by Novelle Pran Bhattacharjee, a product development engineer focused on compliant mechanisms, medical device simplification and sustainable single-use product design.
Register Future Supply Interest
Healthcare buyers, distributors, NGOs, procurement teams and strategic partners can register interest for future pilot production, supply discussions and commercialization updates.
Contact FLX Medtech
For investment, partnership, manufacturing, regulatory or future procurement discussions, contact FLX Medtech.